top of page
icons8-twitterx-100.png
λογότυπο linkedin
λογότυπο facebook
icons8-youtube-100.png

Exploring the iPROLEPSIS Project: Insights from J. Luime

Sep 17, 2024

Innovative Approaches to Monitoring and Managing Psoriatic Arthritis

Jolanda Luime, senior researcher and project partner from Erasmus MC (the Netherlands), shares insights on the iPROLEPSIS project.


The iPROLEPSIS project represents a significant advancement in the field of psoriatic arthritis research. By leveraging cutting-edge technology, including smartphones and data analysis, iPROLEPSIS aims to transform how we measure and understand psoriatic arthritis activity.


Traditional methods of tracking psoriatic arthritis often fall short in capturing the full scope of the disease’s impact. iPROLEPSIS seeks to address this gap by exploring new and innovative approaches. The project uses advanced technology to monitor movement patterns and other key indicators of disease activity, offering a more comprehensive view of how the condition affects patients on a daily basis.


One of the core objectives of iPROLEPSIS is to empower patients with better tools for managing their condition. By providing more detailed insights into disease activity, the project aims to help patients make informed decisions about their health and potentially prevent disease flares before they occur. This proactive approach has the potential to significantly improve the quality of life for those living with psoriatic arthritis.


In addition to benefiting patients, iPROLEPSIS aims to to support clinicians by offering more accurate and actionable data. With better insights into disease activity and treatment effectiveness, healthcare providers can make more informed decisions regarding medication adjustments and overall treatment strategies. This not only enhances patient care but also helps streamline clinical practices, making the process more efficient and effective.


Through the iPROLEPSIS project, the aim is to provide patients and clinicians with the tools they need to better understand and manage psoriatic arthritis, ultimately improving both patient outcomes and clinical practices.






Εγγραφείτε στο ενημερωτικό μας δελτίο

Ευχαριστούμε για την υποβολή!

Λογότυπο iPROLEPSIS

Το έργο iPROLEPSIS λαμβάνει χρηματοδότηση από την Ευρωπαϊκή Ένωση βάσει της Συμφωνίας Επιχορήγησης με Αρ.101095697.

EN-Funded by the EU-PANTONE.png

Χρηματοδοτείται από την Ευρωπαϊκή Ένωση. Ωστόσο, οι απόψεις και οι απόψεις που εκφράζονται είναι αυτές του συγγραφέα ή των συγγραφέων και δεν αντικατοπτρίζουν απαραίτητα εκείνες της Ευρωπαϊκής Ένωσης ή του Ευρωπαϊκού Οργανισμού Υγείας και Ψηφιακής Εκτελεστικής Υπηρεσίας. Ούτε η Ευρωπαϊκή Ένωση ούτε ο Ευρωπαϊκός Εκτελεστικός Οργανισμός Υγείας και Ψηφιακής Υπηρεσίας μπορούν να θεωρηθούν υπεύθυνοι για αυτά.

© 2025 by iPROLEPSIS Consortium

bottom of page